• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Alexion Pharmaceuticals

reign throne chair queen king monarch ruler
Biotech

AstraZeneca's Alexion hopes to extend dominance in PNH

For years, Alexion has been the only name in the game for a disease called paroxysmal nocturnal hemoglobinuria. Now, a number of Big Pharmas want in.
James Waldron Dec 16, 2022 7:25am
Alexions Center of Excellence research lab

AstraZeneca's Alexion, Arvinas nab space at new biotech tower

Apr 15, 2022 9:40am
stop sign

Stealth rare disease drug denied by FDA in I told you so moment

Oct 20, 2021 9:30am
DNA test tube

AstraZeneca’s Alexion taps Genomenon for rare disease work

Sep 20, 2021 10:46am
parachutes

Alexion alums land at complement biotech Kira Pharma

Feb 23, 2021 11:17am
AstraZenecas new Cambridge UK RD center and global HQ - 2nd floor

Alexion pays $100M for Rhythm's speedy review voucher

Jan 6, 2021 10:23am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings